Sanofi teams up with U.S. firm Luminostics on developing COVID-19 testing app
PARIS (Reuters) – French healthcare company Sanofi and U.S. start-up technology company Luminostics said they were joining up to work on developing a smartphone-based self-testing solution to see if someone has the COVID-19 coronavirus.
Luminostics would contribute its proprietary technology for consumer-diagnostics for COVID-19 testing while Sanofi would bring its clinical research testing experience and capabilities, the companies said in a joint statement on Thursday.
Reporting by Sudip Kar-Gupta; Editing by Susan Fenton